Sean co-founded Omada in 2011 with the aim of merging medical trends and cutting edge technology to revolutionize health care of chronic disease as we know it. Today, he proudly serves as CEO and has been instrumental in steering Omada toward global recognition, such as being hailed a potential “medical triumph” by The New York Times, and one of Fast Company’s 50 most innovative companies in the world.
A longtime devotee of healthcare and technology, Sean also founded a largely automated lifestyle business around Excel Everest, the interactive Microsoft Excel training tool he created. He formerly covered healthcare innovation as writer and editor for Medgadget, a popular medical technology blog.
As CEO of Omada, Sean cares deeply about honing the organization’s exceptional products, values-driven approach to healthcare, and the innovative ways in which primary care can continue to better humanity.
More recently, Sean has been spending more and more of his free time learning how to build and fly first-person view drones.
Wei-Li is a global executive and leader with over 20 years of experience building and leading biopharmaceutical and diagnostic imaging businesses in the United States, New Zealand, China, and Taiwan. He came to Omada in 2019 following a rewarding 18-year career as an executive at global pharmaceutical company Eli Lilly and Company.
Wei-Li holds dual Bachelor of Science degrees in biochemistry and molecular biology from the University of Wisconsin-Madison and a Master of Business Administration from the Kelley School of Business, Indiana University.
As Omada’s President, Wei-Li is passionate about the organization’s strong foundations rooted in patient-centered technology, medical-grade evidence, and a scaled business model. His guidance and expertise has helped guide Omada’s expanded product offerings, integration with key partners, leveraging of new business channels, and overall strategic vision. Wei-Li hopes to continue redefining what digital healthcare can be, and should do.
Wei-Li is also a children’s book author having published Anny The Tall Girl, a story of diversity, equity, and inclusion. He and his wife Sarah are the proud parents of two daughters.
Steve has well over a decade of high-level experience working with reputable technology companies in financial strategy. Since joining Omada as its CFO in the summer of 2021, he has been an integral part of executive leadership.
Steve graduated from the University of California, San Diego with a Bachelor of Arts degree in Political Science. He previously worked as Salesforce’s Senior Manager of Finance & Strategy, and One Medical’s Vice President and Head of Strategic Finance.
As CFO, Steve oversees operational activities and guides strategic financial planning and direction to facilitate company growth. He is passionate about furthering Omada’s commitment to deliver personalized, cost-effective digital care to people at-risk and living with chronic conditions.
As a trusted Chief People Officer of mission-driven companies, Nancy has led transformation, business growth, and profitability through people, strategy and culture for leading organizations, including Genentech/Roche, Procter & Gamble, CIGNA, and Deloitte Consulting. With over 25 years of experience, she’s also an award-winning human resources thought leader, known for building great places to work.
As Omada’s Chief People Officer, Nancy leverages her vast industry experience to provide strategic leadership that addresses a wide spectrum of employee and organizational needs. Her expertise drives solutions that help Omada’s team members do their best work and achieve the lofty goals we set for ourselves.
Nancy is a Board Director for a prominent life sciences company and previously for a well known nonprofit. She’s also a Senior Faculty Member of The Josh Bersin Academy, a global development academy for human resources and talent professionals supporting organizations worldwide.
Nancy earned her Bachelor of Business Administration at the University of Michigan’s Stephen M. Ross School of Business. She then completed her graduate studies at Emory University’s Goizueta Business School, achieving a Master of Business Administration.
Nancy enjoys 5k runs with her wife and son, hanging out with friends and exploring new places with her family, whether it's a new local restaurant or a new country.
Nate is Omada’s motivated and talented in-house counsel whose expertise spans a wide range of legal issues. As Omada’s well-respected general counsel, he works closely with company leadership to provide pragmatic, value-driven legal advice in support of the organization’s broader mission––delivering meaningful health outcomes for members.
A graduate of the University of California, Berkeley, School of Law, Nate was previously an Associate at Latham & Watkins LLP, one of the world’s largest multinational law firms. There, he focused on general corporate law, securities law and transactional matters, with an emphasis on internet and technology companies, life sciences companies, venture capital transactions and capital markets.
In his spare time, Nate loves to seek out new culinary experiences by visiting the latest restaurants in San Francisco and trying out elaborate recipes and techniques for his friends and family.
Danika is a growth-oriented executive with 25+ years of experience leading commercial organizations. Before joining Omada, Danika held Chief Marketing Officer roles at high-growth companies in the medical device space and was previously the SVP, Global Marketing at Zeltiq. Earlier in her career, she built global healthcare, consumer, and financial services brands.
She holds a Bachelor of Science degree in Marketing from Georgetown University’s McDonough School of Business and a Master of Business Administration in Marketing from Northwestern University’s Kellogg School of Management.
As Omada’s Chief Product and Growth Officer, Danika brings visionary leadership highlighted by a deep understanding of market trends, customer needs, and strategic planning efforts. She also brings a unique ability to motivate and inspire her teams with an eye toward developing and achieving key organizational growth objectives.
In her free time, Danika enjoys spending time with her husband and children, hiking, and working on home improvement projects. She also loves traveling and exploring new places.
Sunil is a proven technology innovator and strategic business advocate with well over two decades of progressive leadership experience. He specializes in a variety of disciplines, including cloud and software engineering, product development, information technology infrastructure design, technology operations, mobile application development, and global team management.
Throughout his career, he has been motivated by a passion for developing innovative solutions to complex challenges and streamlining operations and business processes to benefit organizations he has worked for, including Fidelity Investments, Eze Software, Chrome River Technologies and Emburse.
As Omada’s Chief Technology Officer, Sunil brings a healthy enthusiasm to his efforts leading a team of highly capable technologists. Under his strategic leadership, Omada’s technology growth and developments are helping drive healthcare modernization and scalable improvements that translate into measurable outcomes for our partners.
Sunil completed his undergraduate studies in computer engineering at Mangalore University in India. He then went on to earn his Master of Science in computer science at the University of South Carolina and a Master of Business Administration from the University of Massachusetts.
In his spare time, you will find Sunil enjoying the outdoors, hiking, biking, boating and during winters snowmobiling in the New Hampshire wilderness.
William has over 20 years of experience protecting and overseeing information security, information technology (IT) operations, and managed services for a host of technology companies. A self-proclaimed “tech geek,” he helped lead Omada through its hyper-growth phase by shaping all aspects of internal IT, end-user support, vendor management, operational security and compliance.
He holds a Bachelor of Science degree in business administration and management from Pepperdine University, and a Master of Science degree in IT security from Capella University. In 2020, William was named a Pepperdine University Outstanding Alumni in Healthcare Honoree. Before coming to Omada, William was RagingWire Data Center’s Senior Vice President and Chief Technology Officer, and StubHub’s Director of Site Operations.
In 2017, William led efforts to make Omada the first digital therapeutics company to achieve both a HITRUST and SOC 2 certification for their services. With healthcare being one of the most breached industries, William takes great pride in helping prevent security lapses from creating a barrier to people receiving the best care possible. His IT and security contributions to Omada’s operations are an integral part of the company’s ability to live up to its mission and values.
William is also an avid nature photographer who captures the essence of Napa Valley’s landmarks and landscapes.
Lucia has over two decades of experience in healthcare across the private, non-profit, and governmental sectors. As Omada’s Chief Privacy & Regulatory Officer, she leads the organization’s regulatory strategy and seamless integration of operations into clinical processes.
A graduate of New York University’s School of Law, Lucia is an experienced C-suite executive and board member. She advises CEOs, Cabinet Secretaries, and elected officials on the optimization of digital healthcare in the 21st Century.
Prior to joining Omada, she served as Chief Privacy Officer at the Office of the National Coordinator for Health IT (ONC). There, she advised the National Coordinator for Health IT and other federal partners about how to ensure privacy and security of health information. Lucia also previously served as the Senior Associate General Counsel at United Healthcare, working with large data transactions related to health information exchanges, healthcare transparency projects, academic research, and other data-driven healthcare innovation projects.
Her storied career and tireless efforts to empower people in search of better healthcare outcomes was recognized by SC Magazine, which named her "one of the largest patient privacy and digital health advocates" in the nation.
Jennifer is an innovative, culture-focused executive with an established national profile. Her vast experience includes heading up outpatient services and clinical programs at multiple health systems, as well as operations and clinical programs for Amazon Care.
She holds a Bachelor of Arts degree in politics from Whitman College and a Master of Arts in political science and government from the University of Wisconsin-Madison.
As an established healthcare executive, Jennifer brings a proven track record to Omada. Her ability to drive and scale complex, cross-functional initiatives from inception to implementation while leading ongoing operations is a key asset to the leadership team. Jennifer’s strength as a culture-focused leader is reflected in the high-performing, highly-engaged teams who consistently meet and exceed targeted goals.
Jennifer is passionate about moving through perceived limits through lifelong practices including meditation and journaling.
Tom is a global healthcare executive with a broad range of digital health and biopharmaceutical experience. Tom joined Omada in 2021 after serving for two decades in leadership positions across multiple healthcare companies including Eli Lilly and Company, GSK and Intercept Pharmaceuticals.
He holds dual Bachelor of Arts degrees in English and Psychology from Vanderbilt University and a Masters of Business Administration from the McCombs School of Business at the University of Texas at Austin.
A multifaceted commercial leader, Tom has led functions including sales, account management, business development, strategy, marketing and market access both in the US and internationally. As Omada’s SVP of Sales and Payer Access, Tom is responsible for growing and maintaining Omada’s partnerships with the nation's leading employers, health plans, health systems and providers.
Prior to his career in healthcare Tom served as a Peace Corps Volunteer in Paraguay. He and his wife, Suse, live in North Carolina with their two daughters.
Allan is a versatile finance executive with a passion for investor relations, corporate finance, and strategy. He previously led investor relations at Cerner Corporation for a 21-year period during which the organization grew into a Fortune 500 company.
Under his leadership, Cerner’s investor relations program was recognized multiple times as a top program within the health care technology and distribution sector by Institutional Investor Magazine.
Allan was drawn to Omada's founder-led, mission-driven culture. He also saw the significant business potential of Omada’s industry leading virtual care platform and is excited to contribute to Omada’s ongoing growth and success.
Allan lives in Kansas City with his wife and three daughters. He enjoys golf and traveling in his free time.
We created this company to inspire and engage people in lifelong health one step at a time.
Sean Duffy
CEO & Co-Founder, Omada Health
Board of Directors
Meet the Omada Board of Directors, a team whose varied backgrounds unite the disciplines of technology, life sciences, and health care delivery.
Sean co-founded Omada in 2011 with the aim of merging medical trends and cutting edge technology to revolutionize health care of chronic disease as we know it. Today, he proudly serves as CEO and has been instrumental in steering Omada toward global recognition, such as being hailed a potential “medical triumph” by The New York Times, and one of Fast Company’s 50 most innovative companies in the world.
A longtime devotee of healthcare and technology, Sean also founded a largely automated lifestyle business around Excel Everest, the interactive Microsoft Excel training tool he created. He formerly covered healthcare innovation as writer and editor for Medgadget, a popular medical technology blog.
As CEO of Omada, Sean cares deeply about honing the organization’s exceptional products, values-driven approach to healthcare, and the innovative ways in which primary care can continue to better humanity.
More recently, Sean has been spending more and more of his free time learning how to build and fly first-person view drones.
Jeryl Hilleman, an experienced corporate director, currently serves as the Chair of the Board for Omada Health. Ms. Hilleman has served on public and private company Boards of Directors for nearly two decades, with current boards including Novocure (Nasdaq: NVCR) and SI-Bone (Nasdaq: SIBN) as well as private companies including the Reiter Affiliated Companies, the international farming arm of Driscoll's Berries. Ms. Hilleman also serves on Board committees including Audit (as Chair), Nominating and Corporate Governance, Compensation, Risk, Pricing, and M&A Committees.
Dr. Beal is a recognized leader in healthcare with a distinguished career in clinical practice, research, and healthcare organizations. She currently serves on the boards of GlaxoSmithKline and Prolacta Biosciences and has held key leadership positions as Chief Patient Officer at Sanofi, Deputy Executive Director and Chief Engagement Officer at the Patient-Centered Outcomes Research Institute (PCORI), and senior roles at the Aetna Foundation and the Commonwealth Fund. Prior to her corporate leadership roles, she was a member of the pediatrics faculty at Harvard Medical School and Massachusetts General Hospital. Dr. Beal earned her medical degree from Cornell University Medical College and completed her residency in pediatrics at Albert Einstein College of Medicine/Montefiore Medical Center. She holds a Master’s in Public Health from Columbia University.
Casper de Clercq holds over 30 years of experience in the medical device and life sciences industry. As a General Partner at Norwest Venture Partners, he brings extensive operating knowledge and focuses on mid-to-late-stage investments in consumer and digital health, healthcare IT, medical devices and diagnostics, technology-enabled healthcare services, and specialty pharmaceuticals. He currently serves on the boards of Clever Care Health Plan, NextHealth Technologies, Omada Health, Robin Healthcare, Monogram Health, and Science Exchange. Casper is also responsible for Norwest’s investment in BillionToOne and Misfit Wearables (acquired by Fossil).
Prior to Norwest, Casper was a Partner at U.S. Venture Partners and the Vice President of Business Development, Sales, and Marketing at Aerogen. In 1999, he co-founded and venture funded Epicor (acquired by St. Jude Medical for over $200M). Casper has also held senior marketing positions at Heartport (acquired by Johnson & Johnson) and Diagnostic Products Corporation (acquired by Siemens).
Casper holds an M.B.A. from Stanford University Graduate School of Business, an M.S. in biological science from Stanford University, and a B.A. in biochemistry from Dartmouth College.
Trevor Fetter is a Senior Lecturer on the faculty of Harvard Business School, where he teaches two required MBA courses.
Before joining the faculty, he was Chairman and Chief Executive Officer of Tenet Healthcare Corp. Under his leadership, the company grew to $20 billion in revenues (Fortune ~#130) and employed 130,000 people. Tenet was one of the ~50 largest employers in the U.S. and had operations in more than 40 states and the United Kingdom.
In addition to teaching, Trevor is an active corporate director, advisor and investor. He currently serves as lead independent director of The Hartford Financial Services Group and serves on the boards of and is an investor in private healthcare services and healthcare technology companies Omada Health, Trimedx Inc., and Regent Surgical Health. He is also a director of the Santa Catalina Island Company. Trevor serves on the board of the Catalina Island Conservancy, the Board of Fellows of Stanford Medicine, and the Smithsonian National Board. At Harvard Business School, he has served on the board of dean’s advisors and the healthcare initiative advisory board.
Trevor received a bachelor’s degree in economics from Stanford University in 1982 and an MBA from Harvard Business School in 1986. He is married to his Stanford classmate, Melissa Fetter, a community volunteer and proprietor of Beacon Hill Books and Café in Boston. Together they were honored with the 2017 Henry Cohn Humanitarian Award presented by the Anti-Defamation League.
CEO of SCAN Group
Sachin Jain, M.D, MBA. is a respected and innovative leader in healthcare with a background in both medicine and healthcare management. Dr. Jain currently serves as CEO of SCAN Group and SCAN Health Plan, Professor of Medicine at Stanford and as a practicing Academic Hospitalist with the U.S. Department of Veterans Affairs. He has had an extensive career, including roles as President and CEO of CareMore Health and Aspire Health; Chief Medical Information & Innovation Officer at Merck & Co; attending physician at the Boston VA-Boston Medical Center; and faculty member at Harvard Medical and Business Schools. Dr. Jain has also held leadership roles at the U.S. Department of Health and Human Services, where he was Senior Advisor to the Administrator of the Centers for Medicare & Medicaid Services (CMS) and currently serves on the boards of America's Health Insurance Plans (AHIP), Advantage Healthcare Services, and The Paul & Daisy Soros Fellowships for New Americans.
Adrian co-founded Omada in 2011 in the hopes of improving public health outcomes through human-centered design. A key member of the executive team and the board of directors, he focuses on bolstering the quality of Omada’s integrated care programs and enhancing member experience.
He also serves as a healthtech advisor for the venture capital and private equity firm Necessary Ventures, and sits on the board of Moving Analytics, Inc., a healthtech company focused on digital prevention and care of heart disease. Prior to co-founding Omada, Adrian led the medical products division of IDEO’s Health Practice, where he focused on business development and client relationships. He holds a Bachelor of Science degree and Master of Science degree in Mechanical Engineering from Stanford University.
Adrian believes wholeheartedly in helping create leadership and entrepreneurial opportunities for historically underrepresented and underserved demographics. He volunteers with the African Diaspora Network as a business mentor the inaugural cohort of the Accelerating Black Leadership & Entrepreneurship (ABLE) program.
Partner Advisor, a16z
Julie Klapstein is a seasoned board member, advisor, entrepreneur. She currently serves as Partner Advisor for a16z and is the founding CEO of Availity, a healthcare IT company working to optimize the automated delivery of critical business and clinical information among healthcare stakeholders. Klapstein has over 30 years of private and corporate experience in the healthcare IT industry, having held executive roles at Phycom, Inc, Sunquest Information Systems, SMS, GTE Health Systems, and AT&T Information Systems, and having served or currently serving on the boards of directors of Amedisys, Alpha II, MultiPlan, NextGen, Oak Street Health, and HCIM.
Vijay Pande, PhD, is a general partner at Andreessen Horowitz, where he focuses on investments in biopharma and healthcare. Pande serves on the boards of Apeel Sciences, BioAge, Devoted Health, Freenome, Insitro, Nobell, Omada Health, Q.bio, and Scribe Therapeutics. Pande is also an Adjunct Professor of Bioengineering at Stanford University, where he continues to advise the Pande Lab, with a focus on tackling challenging problems in chemical biology, biophysics, and biomedicine.
As the founding investor of a16z's Bio Fund, Pande leads the firm's investments at the cross-section of biology and computer science. Areas of focus include applications in computation, machine learning, and artificial intelligence in healthcare, digital therapeutics, diagnostics, and other novel transformative scientific advances applied to an industry that takes bio beyond healthcare.
Previously, Pande was the Henry Dreyfus Professor of Chemistry and Professor of Structural Biology and of Computer Science at Stanford University, where he led a team of researchers pioneering computational methods and their application to medicine and biology (resulting in over 300 publications, two patents, and two novel drug candidates). Pande was also concurrently the Director of the Biophysics program at Stanford, where he led a team of more than 50 faculty members and propelled the program to one of the top in the country.
During his time at Stanford, Pande co-founded Globavir Biosciences, where he translated his research advances into a successful startup that aimed to discover cures for Dengue Fever and Ebola. Pande also founded the Folding@Home Distributed Computing Project for disease research, which pushed the boundaries of computer science techniques (distributed systems, machine learning, and exotic computer architectures) into biology and medicine, in both research as well as the development of new therapeutics.
Pande holds a BA in Physics from Princeton University and a PhD in Physics from MIT. He has been awarded the DeLano Prize in Computation; a Guinness World Record for Folding@Home; the American Chemical Society Thomas Kuhn Paradigm Shift Award; and was selected for MIT TR10. In his teens, Vijay was the first employee at video game startup Naughty Dog Software, the maker of Crash Bandicoot.
Jonathan Root, M.D. has served as a member of Omada’s Board since 2013.
Dr. Root has served as a Managing Member of Presidio Management Group, LLC and several U.S. Venture Partners’ funds, which are the general partners of various other venture capital funds, since 1998. Dr. Root currently serves on the board of directors of Edgewise Therapeutics (NASDAQ: EWTX), Inari Medical (NASDAQ: NARI), Silverback Therapeutics, Inc. (NASDAQ: SBTX) and several private companies in the healthcare industry. Dr. Root joined U.S. Venture Partners as a Ewing Marion Kauffman Fellow in venture capital in 1995.
Before USVP, Dr. Root was an Assistant Professor of Neurology and Director of the Neurology-Neurosurgery Special Care Unit at The New York Hospital - Cornell Medical Center. Dr. Root serves on the Investment Advisory Committee of Mission Bay Capital and the Dartmouth Innovations Accelerator for Cancer External Review Panel. Dr. Root is a former board member of the National Venture Capital Association.
Dr. Root received an A.B. from Dartmouth College, an M.D. from University of Florida, College of Medicine and an M.B.A. from Columbia Business School.
Former SVP of U.S. Benefits, Walmart
Adam Stavisky joins the Omada Board, having most recently served as the SVP of U.S. Benefits for Walmart, where he was responsible for Walmart’s strategic vision and for delivery of all benefits for 1.6 million associates across its U.S. businesses. During his tenure, Stavisky championed system improvements to drive better patient outcomes for Walmart employees. Earlier in his career, Stavisky spent more than 20 years building benefits consulting businesses at several national firms, including Fidelity Investments, Mercer, and Aon Hewitt (formerly Hewitt Associates).
.jpg)
